Atrial Fibrillation

Abbott begins clinical development of a pulsed field ablation device

By Nick Paul Taylor

Abbott has begun clinical development of a pulsed field ablation (PFA) device that could rival Boston Scientific, Johnson & Johnson, and Medtronic for an emerging atrial fibrillation (AFib) market.

January 24, 2024

Revenues from coagulation lab and POC tests near $4B in 2021

By Bruce Carlson

Hemostasis (coagulation) is a complex process in which multiple enzymes and proteins regulate blood flow and clot formation. Coagulation (clot formation), fibrinolysis (the breakup of blood clots), and platelet aggregation are a part of this process.

February 15, 2022

Inflammatory marker sCD14 lurks in dementia

By Emily Hayes

Earlier detection of dementia using convenient blood tests is an important goal for Alzheimer's disease and other dementia disorders so that patients can be identified in time to be included in clinical trials and hopefully treated successfully. Inflammation and infection have become intriguing areas of research in Alzheimer's disease.

December 10, 2019

Invitae deploys Apple Watch for cardiovascular genetics study

By LabPulse.com staff writers

The first application of the platform -- dubbed Invitae Discover -- will be cardiovascular disease, the company said in an announcement ahead of the of the American Heart Association (AHA) annual meeting taking place November 16-18 in Philadelphia.

November 14, 2019

Researchers to study media coverage of 'overdiagnosis' tests

By LabPulse.com staff writers

Dr. Mary O'Keeffe from the University of Sydney and colleagues will investigate media coverage of the following five tests:

August 26, 2019